CompletedPhase 2

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

NCT01336738

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pfizer Investigational Site

Jonesboro, Arkansas, United States

+43 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2011-06
Enrollment: 266 participants
Sponsor: Pfizer
Purpose: treatment

Locations (44)

Pfizer Investigational SiteJonesboro, Arkansas, United States
Pfizer Investigational SiteJonesboro, Arkansas, United States
Pfizer Investigational SiteLos Angeles, California, United States
Pfizer Investigational SitePalm Springs, California, United States
Pfizer Investigational SiteJacksonville, Florida, United States
Pfizer Investigational SiteMelbourne, Florida, United States
Pfizer Investigational SiteWest Palm Beach, Florida, United States
Pfizer Investigational SiteConyers, Georgia, United States
Pfizer Investigational SiteChicago, Illinois, United States
Pfizer Investigational SiteLouisville, Kentucky, United States
Pfizer Investigational SiteFall River, Massachusetts, United States
Pfizer Investigational SiteBrooklyn, New York, United States
Pfizer Investigational SiteCary, North Carolina, United States
Pfizer Investigational SiteWilmington, North Carolina, United States
Pfizer Investigational SiteColumbus, Ohio, United States
Pfizer Investigational SiteEast Providence, Rhode Island, United States
Pfizer Investigational SiteEast Providence, Rhode Island, United States
Pfizer Investigational SiteMt. Pleasant, South Carolina, United States
Pfizer Investigational SiteBristol, Tennessee, United States
Pfizer Investigational SiteKingsport, Tennessee, United States
Pfizer Investigational SiteDallas, Texas, United States
Pfizer Investigational SiteHouston, Texas, United States
Pfizer Investigational SiteHouston, Texas, United States
Pfizer Investigational SiteHouston, Texas, United States
Pfizer Investigational SiteSan Antonio, Texas, United States
Pfizer Investigational SiteCharlottesville, Virginia, United States
Pfizer Investigational SiteKenosha, Wisconsin, United States
Pfizer Investigational SiteMilwaukee, Wisconsin, United States
Pfizer Investigational SiteWinnipeg, Manitoba, Canada
Pfizer Investigational SiteStrathroy, Ontario, Canada
Pfizer Investigational SiteThornhill, Ontario, Canada
Pfizer Investigational SiteToronto, Ontario, Canada
Pfizer Investigational SiteLaval, Quebec, Canada
Pfizer Investigational SiteSaint Romuald, Quebec, Canada
Pfizer Investigational SiteBudapest, Hungary
Pfizer Investigational SiteGuadalajara, Jalisco, Mexico
Pfizer Investigational SiteGuadalajara, Jalisco, Mexico
Pfizer Investigational SiteMonterrey, Nuevo León, Mexico
Pfizer Investigational SiteBratislava, Slovakia
Pfizer Investigational SiteSeoul, South Korea
Pfizer Investigational SiteSeoul, South Korea
Pfizer Investigational SiteSeoul, South Korea
Pfizer Investigational SiteTainan, Taiwan
Pfizer Investigational SiteTaipei, Taiwan